Home › Stocks › GSK › All Fund Holders
GSK — GSK PLC · All Fund Holders
Funds holding (latest): 42 · Reported value held: $8.81B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 64.96M | $3.41B | 0.16% | Reduce |
| Dodge & Cox history | Q2 2026 | 48.20M | $2.53B | 1.32% | Reduce |
| Wellington Management Group history | Q2 2026 | 11.40M | $597.39M | 0.11% | Reduce |
| Morgan Stanley history | Q2 2026 | 7.66M | $401.41M | 0.02% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 6.37M | $333.99M | 0.03% | Reduce |
| BlackRock Inc history | Q2 2026 | 3.62M | $189.78M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 2.86M | $149.99M | 0.02% | Add |
| Point72 Asset Management history | Q2 2026 | 2.66M | $139.50M | 0.16% | New |
| Bank of America Corp history | Q2 2026 | 2.22M | $116.21M | 0.01% | Hold |
| JPMorgan Chase & Co history | Q2 2026 | 2.09M | $110.11M | 0.01% | New |
| Manulife Financial history | Q2 2026 | 1.89M | $98.96M | 0.08% | Reduce |
| Northern Trust Corp history | Q2 2026 | 1.75M | $91.97M | 0.01% | Hold |
| Arrowstreet Capital history | Q2 2026 | 1.63M | $85.60M | 0.04% | Add |
| Capital Research Global Investors history | Q3 2025 | 1.79M | $77.45M | 0.01% | Add |
| Wells Fargo & Co history | Q2 2026 | 1.36M | $71.36M | 0.01% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 1.09M | $56.93M | 0.03% | Add |
| Citigroup Inc history | Q2 2026 | 1.00M | $52.52M | 0.02% | Reduce |
| Franklin Resources history | Q2 2026 | 939.80K | $49.26M | 0.01% | Hold |
| Citadel Advisors history | Q2 2026 | 870.87K | $45.65M | 0.01% | Reduce |
| BNY Mellon history | Q2 2026 | 838.77K | $43.97M | 0.01% | Add |
| Bridgewater Associates history | Q2 2026 | 504.17K | $26.43M | 0.11% | Reduce |
| Millennium Management history | Q2 2026 | 398.60K | $20.89M | 0.01% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 388.71K | $20.38M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 346.16K | $18.15M | 0.01% | Add |
| Renaissance Technologies history | Q1 2026 | 311.29K | $17.18M | 0.03% | Reduce |
| MFS Investment Management history | Q2 2026 | 319.81K | $16.76M | 0.01% | Add |
| PNC Financial Services history | Q2 2026 | 219.51K | $11.51M | 0.01% | Hold |
| Norges Bank Investment Management history | Q2 2026 | 200.00K | $10.48M | 0.00% | New |
| Moore Capital Management history | Q3 2023 | 187.09K | $6.78M | 0.13% | Reduce |
| Two Sigma Investments history | Q2 2026 | 70.99K | $3.72M | 0.00% | Add |
| Amundi US history | Q2 2026 | 61.99K | $3.25M | 0.00% | Reduce |
| Lazard Asset Management history | Q2 2026 | 56.04K | $2.94M | 0.01% | Add |
| Prudential Financial history | Q3 2024 | 69.27K | $2.83M | 0.00% | Reduce |
| Pzena Investment Management history | Q2 2026 | 24.51K | $1.28M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 23.17K | $1.21M | 0.00% | New |
| Balyasny Asset Management history | Q4 2025 | 15.96K | $782.83K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 12.16K | $637.53K | 0.00% | Reduce |
| Causeway Capital Management history | Q2 2026 | 7.16K | $375.47K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 6.92M | $362.94K | 0.04% | Reduce |
| Invesco Ltd history | Q2 2026 | 4.86K | $254.65K | 0.00% | Add |
| Fidelity International (FIL) history | Q2 2026 | 888 | $46.55K | 0.00% | Add |
| First Eagle Investment Management history | Q1 2023 | 3 | $101 | 0.00% | Reduce |